Castle Biosciences Income Statement (2018-2025) | CSTL

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 3.98M3.71M11.44M8.72M10.74M14.77M17.64M17.42M12.71M15.22M17.30M22.81M22.76M23.48M25.04M26.85M34.84M37.01M38.34M42.04M50.14M61.49M66.12M72.97M87.00M85.78M86.31M87.99M86.19M83.04M
Cost of Revenue 1.25M1.35M1.37M1.60M1.99M1.71M2.01M2.39M2.15M2.48M2.67M3.03M3.70M4.50M4.60M5.94M7.69M8.86M9.52M10.18M11.06M11.32M12.42M13.89M14.52M15.61M16.18M16.38M17.63M18.70M
Gross Profit 2.65M2.36M10.07M7.12M8.75M13.07M15.62M15.03M10.57M12.74M14.63M19.79M19.06M18.98M20.44M20.91M27.15M28.15M28.82M31.86M39.08M50.17M53.70M59.08M72.48M70.17M70.13M71.61M68.56M64.34M
Operating items
Amortization - Intangibles 0.30M0.70M1.00M1.65M2.10M2.31M2.20M2.22M2.25M2.30M2.27M2.25M2.25M2.30M4.31M28.32M2.00M2.30M
Research & Development 1.26M1.29M1.14M1.39M1.32M1.51M3.16M2.91M2.70M3.06M4.58M5.91M6.79M7.50M9.45M10.76M11.93M10.91M11.31M14.39M13.31M12.92M12.99M13.81M14.14M12.32M11.77M12.59M12.79M12.96M
Selling, General & Administrative 4.23M3.92M4.17M6.05M6.82M7.12M9.85M11.08M10.39M11.70M14.96M18.16M20.82M22.59M25.16M30.45M37.50M36.63M38.43M46.76M44.68M44.62M44.09M48.49M51.09M50.50M49.97M58.62M58.06M55.91M
Other Operating Expenses -52.00415.000.26M3.95M5.19M5.61M10.15M-10.62M11.01M11.44M12.40M13.31M13.59M14.69M16.14M16.77M17.88M20.52M44.71M19.59M20.98M
Operating Expenses 5.49M5.21M5.30M7.44M8.14M8.64M13.01M13.99M13.36M14.76M19.54M24.07M31.57M35.29M40.21M51.37M38.81M58.55M61.17M73.56M71.30M71.13M71.78M78.44M81.99M80.70M82.26M115.92M90.44M89.85M
Operating Income -3.08M-2.85M4.77M-0.32M0.61M4.43M2.61M1.04M-0.65M-3.90M-3.03M-4.28M-8.81M-11.81M-15.17M-24.52M-3.97M-21.54M-22.83M-31.52M-21.16M-9.64M-5.66M-5.47M5.01M5.08M4.05M-27.93M-4.25M-6.80M
EBIT -3.08M-2.85M4.77M-0.32M0.61M4.43M2.61M1.04M-0.65M-3.90M-3.03M-4.28M-8.81M-11.81M-15.17M-24.52M-3.97M-21.54M-22.83M-31.52M-21.16M-9.64M-5.66M-5.47M5.01M5.08M4.05M-27.93M-4.25M-6.80M
Non-operating items
Interest & Investment Income 0.01M0.01M0.00M0.02M0.01M0.01M0.28M0.30M0.04M0.02M0.02M0.00M0.02M0.02M0.02M0.03M0.37M1.29M2.27M2.34M2.40M2.77M3.12M3.00M3.14M3.40M3.37M3.10M2.94M2.83M
Other Non Operating Income -0.02M-0.04M-0.24M-0.03M-0.19M5.20M-1.40M0.05M
Non Operating Income -0.02M-0.04M-0.24M-0.03M-0.19M-2.71M0.05M
Net income details
EBT -3.63M-3.45M3.88M-1.36M-1.27M5.85M2.13M0.57M-1.38M-4.59M-4.80M-4.28M-8.79M-11.79M-15.15M-24.49M-3.60M-20.25M-20.56M-29.19M-18.76M-6.87M-2.54M-2.49M7.89M8.28M7.88M-26.27M-0.14M-0.39M
Tax Provisions 0.01M0.07M0.08M0.01M-8.72M0.13M-1.96M0.06M0.01M0.02M0.03M0.04M0.04M-1.03M6.01M-1.71M-0.42M-4.70M0.12M
Profit After Tax -3.15M-3.45M3.87M-1.36M-1.27M5.85M2.06M0.57M-1.38M-4.59M-4.89M-4.28M-8.79M-11.79M-6.43M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.52M-0.50M
Equity Income 0.60M-1.43M1.20M3.60M
Income from Continuing Operations -3.63M-3.45M3.87M-1.36M-1.27M5.85M2.06M0.57M-1.38M-4.59M-4.89M-4.28M-8.79M-11.79M-6.43M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.56M-0.50M
Consolidated Net Income -3.63M-3.45M3.87M-1.36M-1.27M5.85M2.06M0.57M-1.38M-4.59M-4.89M-4.28M-8.79M-11.79M-6.43M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.56M-0.50M
Income towards Parent Company -3.63M-3.45M3.87M-1.36M-1.27M5.85M2.06M0.57M-1.38M-4.59M-4.89M-4.28M-8.79M-11.79M-6.43M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.56M-0.50M
Preferred Dividend Payments 0.81M0.95M0.95M0.93M0.94M0.29M
Net Income towards Common Stockholders -4.08M-4.46M2.86M-2.34M-2.27M5.54M2.06M0.57M-1.38M-4.59M-4.89M-4.28M-8.79M-11.79M-6.43M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.56M-0.50M
Additional items
EPS (Basic) -2.15-2.331.49-1.22-1.050.430.120.03-0.08-0.23-0.23-0.17-0.35-0.47-0.25-0.97-0.06-0.77-0.79-1.10-0.70-0.26-0.09-0.090.320.080.35-0.900.16-0.02
EPS (Weighted Average and Diluted) -2.15-2.330.38-1.22-1.050.050.110.03-0.08-0.23-0.23-0.17-0.35-0.47-0.25-0.97-0.06-0.77-0.79-1.10-0.70-0.26-0.09-0.090.310.080.32-0.900.15-0.02
Shares Outstanding (Weighted Average) 15.46M15.46M17.07M17.07M17.07M17.19M17.22M19.68M19.91M24.98M25.06M25.17M25.30M25.41M26.26M26.30M26.35M26.58M26.69M26.81M26.91M27.45M27.61M27.74M28.01M28.51M28.87M29.01M
Shares Outstanding (Diluted Average) 1.91M1.91M1.92M2.15M14.30M8.66M18.73M17.54M19.94M18.93M24.91M25.09M25.29M25.14M25.42M26.06M26.32M26.05M26.61M26.73M26.83M26.80M27.48M28.74M29.40M29.25M28.61M29.55M29.07M
EBITDA -3.63M-3.45M3.87M-1.36M-1.27M5.85M2.06M0.57M-1.38M-4.59M-4.89M-4.28M-8.79M-11.79M-6.43M-24.62M-1.65M-21.54M-22.83M-31.52M-21.16M-9.64M-5.66M-5.47M5.01M5.08M4.05M-27.93M-4.25M-6.80M
Interest Expenses 0.53M0.57M0.65M1.02M1.69M1.09M0.77M0.76M0.77M0.71M0.40M0.00M0.00M0.00M0.01M0.00M0.00M0.00M0.00M0.00M0.01M0.27M0.20M0.09M0.02M0.02M0.02M
Tax Rate 0.23%3.39%57.57%54.29%72.60%1.61%